Wenham RM - Search Results

1

Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival.

Bush SH, Tollin S, Marchion DC, Xiong Y, Abbasi F, Ramirez IJ, Zgheib NB, Boac B, Judson PL, Chon HS, Wenham RM, Apte SM, Cubitt CL, Berglund AE, Havrilesky LJ, Lancaster JM. Bush SH, et al. Among authors: wenham rm. Mol Clin Oncol. 2016 Mar;4(3):399-404. doi: 10.3892/mco.2016.725. Epub 2016 Jan 7. Mol Clin Oncol. 2016. PMID: 26998291 Free PMC article.

2

Molecular aspects of ovarian cancer.

Wenham RM, Lancaster JM, Berchuck A. Wenham RM, et al. Best Pract Res Clin Obstet Gynaecol. 2002 Aug;16(4):483-97. doi: 10.1053/beog.2002.0298. Best Pract Res Clin Obstet Gynaecol. 2002. PMID: 12413930 Review.

3

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, Bentley RC, Berchuck A, Schildkraut JM. Lancaster JM, et al. Among authors: wenham rm. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):226-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646513 No abstract available.

4

Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.

Wenham RM, Calingaert B, Ali S, McClean K, Whitaker R, Bentley R, Lancaster JM, Schildkraut J, Marks J, Berchuck A. Wenham RM, et al. J Soc Gynecol Investig. 2003 Sep;10(6):381-7. doi: 10.1016/s1071-5576(03)00141-2. J Soc Gynecol Investig. 2003. PMID: 12969782

5

MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Wei Z, Kamath S, Chen DT, Dressman H, Lancaster JM. Boren T, et al. Gynecol Oncol. 2008 Aug;110(2):206-15. doi: 10.1016/j.ygyno.2008.03.023. Epub 2008 May 21. Gynecol Oncol. 2008. PMID: 18499237

6

MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.

Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Chan G, Kamath SG, Chen DT, Dressman H, Lancaster JM. Boren T, et al. Gynecol Oncol. 2009 May;113(2):249-55. doi: 10.1016/j.ygyno.2009.01.014. Epub 2009 Feb 23. Gynecol Oncol. 2009. PMID: 19237188

7

Evaluation of the porcine model to teach various ancillary procedures to gynecologic oncology fellows.

Hoffman MS, Ondrovic LE, Wenham RM, Apte SM, Shames ML, Zervos EE, Weinberg WS, Roberts WS. Hoffman MS, et al. Among authors: wenham rm. Am J Obstet Gynecol. 2009 Jul;201(1):116.e1-3. doi: 10.1016/j.ajog.2009.04.050. Am J Obstet Gynecol. 2009. PMID: 19576378

8

Electrothermal bipolar coagulation decreases the rate of red blood cell transfusions for pelvic exenterations.

Bansal N, Roberts WS, Apte SM, Lancaster JM, Wenham RM. Bansal N, et al. Among authors: wenham rm. J Surg Oncol. 2009 Nov 1;100(6):511-4. doi: 10.1002/jso.21372. J Surg Oncol. 2009. PMID: 19697350

9

Gedunin, a novel natural substance, inhibits ovarian cancer cell proliferation.

Kamath SG, Chen N, Xiong Y, Wenham R, Apte S, Humphrey M, Cragun J, Lancaster JM. Kamath SG, et al. Int J Gynecol Cancer. 2009 Dec;19(9):1564-9. doi: 10.1111/IGC.0b013e3181a83135. Int J Gynecol Cancer. 2009. PMID: 19955938

10

Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin.

Indermaur MD, Xiong Y, Kamath SG, Boren T, Hakam A, Wenham RM, Apte SM, Lancaster JM. Indermaur MD, et al. Among authors: wenham rm. Am J Obstet Gynecol. 2010 Aug;203(2):158.e1-40. doi: 10.1016/j.ajog.2010.02.003. Epub 2010 May 4. Am J Obstet Gynecol. 2010. PMID: 20444440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page